Davita Healthcare Partners, Inc. (NYSE:DVA)
The Company is a provider of dialysis services in the United States for patients suffering from chronic kidney failure, also known as end stage renal disease.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
Recs
within 3 years, uncle warren will add this one outright to the berkshire mutual fund.
Recs
Buffett approved; Bespoke approved; One of Berkshire's best niche plays; Makes real money all the time; might go down somewhat -so what -buy more!!
Recs
Buffet floor in this one, growing need for services, cost born by govt.
Recs
They are the dominant player in their industry with a lot of room to grow, including expanding internationally
Recs
Warren Buffett has been buying DVA as though it were a cold Coke on a hot day. Fourth quarter 2012 purchases were at least 3.4 million shares, giving him over 14% of shares outstanding and a 33% increase in his position.
Recs
Expansion into revolutionizing primary care is a cherry on top of a solid business. Good enough for Buffet, good enough for me!
Recs
Recs
Buffett's Berkshire just increased their stakes in Davita which provides dialysis services (also meets Peter Lynch's "yuckiness" factor) for failed kidneys. It is at an all-time high which seems like an unusual value purchase.
Recs
Tops on Fortune list of most admired companies. Tops in some other list of copanies that train their employees well.
Recs
Increasing customer base, company knows how to manage financials
Recs
Showed up on a screen for solid 5 year growth with low debt, cash on hand and still at attractive P/E ratios.
Recs
This company's product is absolutely unrelated to any other aspect of the economy. All dialysis patients need and will receive dialysis, regardless of economics. The government pays the bills and will continue to do so. Costs are completely predictable and the company has managed them skillfully over the past eight years.
The company can predict revenue, cost, and earnings, with almost 100% accuracy, well into the future.
This is a no-brainer.
Recs
In America obesity and diabetes are growing which leads to kisney failure. More and more Americans are ending up on dialysis machines and Davita is the leading company in America. It is the Mcdonalds of dialysis. There is one on every corner, you just don't see them.
Recs
$60+/share
Recs
Incredible Management, finishing the integration of their acquisition of the largest competitor.
Recs
kidney failure is up in the us
Recs
With overwieght, and alcohol drinking America Kidney desease and dialysis is growing. This company should grow as well
Recs
healthcare play!
Recs
Breakout of basing pattern on above average volume. Target $80
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 32 : 1 2 Next »